WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year – – ...

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

Dogs Maymo and Potpie rescue a baby werewolf in a funny Halloween.

US$0.40 loss per share (further deteriorated from US$0.39 loss in 1Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Looking ...

Werewolf Therapeutics announced its first quarter 2025 financial results and business updates, highlighting significant progress in its clinical programs. The comp ...

A budding Hartlepool author has published his first dark fiction novel after completing a short story course to “pass the ...

Werewolf Therapeutics updates on clinical trials, financial results, and plans for proprietary T cell engager development amidst strong cash position. Werewolf Therapeutics, Inc. announced ...

WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year - - First patient dosed in the Phase 1b/2 clinical trial of WTX-330, seeking ...

These 20 highest-rated werewolf movies will not only send shivers down your spine but also ensure complete entertainment.

Romeo + Juliet remains one of the original forbidden romances, inspiring centuries of stories of star-crossed lovers.

"You sent me the invite to play here, didn't you? You set this whole thing so my band would get killed off..." While we're ...

WATERTOWN, Mass. - Werewolf Therapeutics, Inc. (NASDAQ:HOWL), a biopharmaceutical company specializing in immune system-stimulating therapeutics with a current market capitalization of $40.6 ...